MedCity News
MAY 15, 2025
Israeli cancer diagnostics startup SpoititEarly launched in the U.S. It is developing a test that uses AI and trained canines to analyze patients breath samples, with the goal of detecting cancer at its earliest stages. The company plans to begin selling the at-home test to U.S. consumers next year. The post Meet the Startup Using Dogs to Sniff Out Cancer appeared first on MedCity News.
PharmaVoice
MAY 16, 2025
A stealth startup built by the partner of disgraced Theranos founder Elizabeth Holmes is taking a shot at a new blood test — an area where other companies are already making strides.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Sales Talent
MAY 15, 2025
Hiring the right salesperson can make all the difference in your sales team’s success. Whether you’re a business owner aiming to build a high-performing sales team or a sales professional striving to reach peak performance, understanding the qualities of a good salesperson is vital. The best salespeople don’t simply sell; they build trust, solve problems, and drive growth.
pharmaphorum
MAY 16, 2025
In a medical breakthrough, a child diagnosed with a rare genetic disorder has received a bespoke CRISPR gene editing therapy to correct the mutation
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
MedCity News
MAY 12, 2025
Eli Lilly reported that in addition to achieving greater reductions in weight, Zepbound-treated patients achieved greater reductions in waist circumference compared to those treated with Novo Nordisks Wegovy. Full details from the head-to-head Phase 3 test were presented at the European Congress on Obesity meeting. The post Details From Head-to-Head Phase 3 Test Give Fuller Picture of Zepbounds Edge Over Wegovy appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
PharmaTimes
MAY 14, 2025
Trial progresses towards topline data expected later in the year
Dominic Tyer
MAY 13, 2025
Now that Ive started taking on freelance clients for editorial work the one piece missing from my time online feels like it’s something thats dedicated to digital pharma.
MedCity News
MAY 12, 2025
The trouble is that our technical colleagues know how to build beautiful products, but most have not worked within the four walls of healthcare, very seldom within the operating room. As a result, they do not know what will work or what is sufficient to drive engagement. What’s needed is collaboration. The post Why Clinician Involvement is Essential to Driving Hospital Innovation appeared first on MedCity News.
PharmaVoice
MAY 12, 2025
But the therapies will need to prove their worth in the clinic over the next few years.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
PharmaTimes
MAY 15, 2025
Aspire-FTD study aims to stop disease progression with one-time treatment
Pharmaceutical Technology
MAY 15, 2025
The FDA has approved MSDs Welireg for rare adrenal tumours, and AbbVies Emrelis for treating c-Met+ lung cancer patients.
MedCity News
MAY 13, 2025
Women most affected by both functional and serious GI conditions, especially in midlife, are often dismissed, misdiagnosed, or forced to endure prolonged waits for specialist care. The post Dismissed, Delayed and Done Waiting: The GI Crisis Midlife Women Cant Afford appeared first on MedCity News.
PharmaVoice
MAY 15, 2025
Amy Parison, who stepped into the lead financial role at the company in March, is managing Editas Medicine’s transition to a new gene editing platform while recovering from a major overhaul.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
pharmaphorum
MAY 16, 2025
Datavant and Aetion merger promises "faster, more actionable" real-world data insights across pharma's clinical and commercial lifecycle
Pharmaceutical Technology
MAY 16, 2025
The Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) was terminated in April.
MedCity News
MAY 16, 2025
Perhaps the most significant health policy of our time, it revolutionized coverage and access, as well as the way healthcare companies communicated.With its future uncertain, now is the time to look back on how it shaped a new era of healthcare marketing strategy and messaging. The post The Affordable Care Acts Lasting Impact On Healthcare Marketing appeared first on MedCity News.
Pharma Marketing Network
MAY 16, 2025
In today’s digital landscape, the integration of artificial intelligence (AI) into healthcare social media marketing is revolutionizing how organizations engage with patients and professionals. As AI technologies become more sophisticated, they offer unprecedented opportunities to personalize content, predict trends, and optimize campaigns. This evolution is not just a trend but a fundamental shift in how healthcare entities communicate and build trust with their audiences.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
MAY 15, 2025
Sanofi is the latest European pharma group to promise a big capital investment programme on manufacturing and R&D in the US
PharmaTimes
MAY 14, 2025
FDA recognises KER-0193 as a potential therapy for rare paediatric disease
MedCity News
MAY 15, 2025
To prepare for an autonomous surgical future, medtech leaders should explore the practical implications of potential scenarios, and structure investment accordingly. The key is to develop a living roadmap that drives decisions on a day-by-day basis, drawing on macro- and micro-trends. The post Imagine Reshaping The Surgical Landscape With Autonomous Surgery appeared first on MedCity News.
Pharma Marketing Network
MAY 12, 2025
Ever tried shouting in a crowded stadium? Thats what it feels like launching a branded healthcare campaign today. With every pharma brand, health system, and startup clamoring for attention, crafting a successful healthcare marketing strategy has never been more challengingor more necessary. In 2025, reaching healthcare professionals (HCPs), patients, and caregivers requires more than budget and brand equity.
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
pharmaphorum
MAY 14, 2025
GSK decided to abandon a TIGIT-targeted drug for cancer this week, then hatched a plan to replace it with a candidate for liver disease MASH.
Pharmaceutical Technology
MAY 16, 2025
The deal gives Lilly access to the companys RNA-editing platform to develop therapies for sensorineural hearing loss.
MedCity News
MAY 13, 2025
By creating payment experiences that feel less like a burden and more like the seamless, convenient, flexible transactions patients experience elsewhere, we can significantly improve both patient satisfaction and financial performance. The post Bridging Financial Services and Healthcare appeared first on MedCity News.
eMediWrite
MAY 15, 2025
In the evolving world of healthcare, one trend is reshaping how pharmaceutical brands engage the market: the shift from product-centred to patient-centred marketing. Gone are the days when success was defined solely by product efficacy or sales numbers. Today, the true differentiator is how well we understand, empathise with, and support the real people behind every prescription.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
pharmaphorum
MAY 12, 2025
Researchers have developed an AI that could help doctors predict a patient's chance of surviving cancer and potentially guide treatment decisions
Pharmaceutical Technology
MAY 16, 2025
Pathos AI has raised $365m in a Series D funding round to widen its AI-enabled platform to advance the development of oncology drugs.
MedCity News
MAY 16, 2025
Inozyme Pharmas main asset is in pivotal testing in children who have a rare enzyme deficiency that affects bones and blood vessels. BioMarin Pharmaceutical, already well established in enzyme replacement, said it will use its experience and infrastructure to grow the market for this product, potentially for several indications. The post BioMarins $270M Inozyme Acquisition Brings Drug That Could Become First for a Rare Disease appeared first on MedCity News.
Expert insights. Personalized for you.
290 
Let's personalize your content